These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 9141838

  • 1. Amphotericin B in visceral leishmaniasis.
    Jha BB.
    Indian Pediatr; 1996 Nov; 33(11):971. PubMed ID: 9141838
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of visceral leishmaniasis unresponsive to pentamidine with amphotericin B.
    Mishra M.
    J Assoc Physicians India; 1995 Apr; 43(4):306. PubMed ID: 8713286
    [No Abstract] [Full Text] [Related]

  • 3. Challenges in the management of visceral leishmaniasis.
    Sundar S, Kumar A.
    Indian Pediatr; 2005 Jun; 42(6):523-6. PubMed ID: 15995268
    [No Abstract] [Full Text] [Related]

  • 4. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB, Yang CM, Zhang CJ.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti leishmanial therapy--the changing scene.
    Bichile LS.
    J Assoc Physicians India; 1994 Sep; 42(9):682-3. PubMed ID: 7883657
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of localized cutaneous leishmaniasis].
    Buffet P, Caumes E, Gentilini M.
    Ann Dermatol Venereol; 1994 Sep; 121(6-7):503-11. PubMed ID: 7702288
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sodium antimony gluconate, amphotericin, and myocardial damage.
    Thakur CP.
    Lancet; 1998 Jun 27; 351(9120):1928-9. PubMed ID: 9654264
    [No Abstract] [Full Text] [Related]

  • 15. Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine.
    Kumar D, Ramesh V, Verma S, Ramam M, Salotra P.
    Ann Trop Med Parasitol; 2009 Dec 27; 103(8):727-30. PubMed ID: 20030997
    [No Abstract] [Full Text] [Related]

  • 16. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK, Bhattacharya SK.
    Natl Med J India; 2005 Dec 27; 18(3):131-3. PubMed ID: 16130613
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Liposomal amphotericin B cured two cases of visceral leishmaniasis tolerant to sodium antimony gluconate].
    Yuan QR.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Jun 30; 28(3):209, 213. PubMed ID: 20806506
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.